Brief: Cardiol Therapeutics Files For Mixed Shelf Offering Of Up To $150 Mln
10/09/2026 17:46
BRIEF-Cardiol Therapeutics Files For Mixed Shelf Offering Of Up To $150 Mln Sept 10 (Reuters) - Cardiol Therapeutics Inc CRDL.TO:
CARDIOL THERAPEUTICS INC : FILES FOR MIXED SHELF OFFERING OF UP TO $150 MILLION- SEC FILING
Source text: [ID:n0001104659-26-106628]
Further company coverage: CRDL.TO
(((( Reuters.Briefs@thomsonreuters.com ;));))
Recent news on Cardiol Therapeutics
See all newsBrief: Cardiol Therapeutics Achieves Phase III Maveric Enrollment Target Ahead Of Schedule And Expands Pivotal Trial To Strengthen Assessment Of Cardiolrx's Efficacy
Brief: Cardiol Therapeutics Files US$150 Million Preliminary Base Shelf Prospectus
Brief: Cardiol Therapeutics Files For Mixed Shelf Offering Of Up To $150 Mln
Brief: Cardiol Therapeutics Initiated Pivotal Phase Iii Maveric Trial Of Cardiolrx In Recurrent Pericarditis
NASDAQ RESUMED AT 09:00 AM